Literature DB >> 22956729

Aspirin and cancer prevention and treatment: are we there yet?

John D Potter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22956729     DOI： 10.1158/1055-9965.EPI-12-0837

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

Review 1.  Prevention and treatment of cancer with aspirin: where do we stand?

Authors:  Boris Pasche; Minghui Wang; Michael Pennison; Hugo Jimenez
Journal:  Semin Oncol       Date:  2014-04-24       Impact factor: 4.929

2.  Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.

Authors:  Dominique Scherer; Lisel M Koepl; Elizabeth M Poole; Yesilda Balavarca; Liren Xiao; John A Baron; Li Hsu; Anna E Coghill; Peter T Campbell; Sarah E Kleinstein; Jane C Figueiredo; Johanna W Lampe; Katharina Buck; John D Potter; Richard J Kulmacz; Mark A Jenkins; John L Hopper; Aung K Win; Polly A Newcomb; Cornelia M Ulrich; Karen W Makar
Journal:  Genes Chromosomes Cancer       Date:  2014-03-28       Impact factor: 5.006

3.  Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.

Authors:  David B Liesenfeld; Akke Botma; Nina Habermann; Reka Toth; Christoph Weigel; Odilia Popanda; Karel D Klika; John D Potter; Johanna W Lampe; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-19       Impact factor: 4.254
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.